Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris.Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired by…
- Homepage
- North America
- North America Legal Chronicle
- Viatris’ Acquisition of Oyster Point Pharma
Viatris’ Acquisition of Oyster Point Pharma
Tagged: 16-11-2022 Amanda Griggs Amanda Hines Gold Andrew Wark Anna Mikaelyan Brandon Fenn Carys Webb Charity Williams Christopher Davis Christopher Winters Colette Ghazarian Cooley LLP Cravath Swaine & Moore David Kappos Div Gupta Eashaa Parekh Eileen Marshall Howard Morse Ian Nussbaum J. Leonard Teti II John Paul Oleksiuk John Robertson Jonathan Katz Julia Brinton Kimberly Bolin Kiran Sheffrin Liz Gold Margaret Segall D’Amico Mark Greene Matteo Sica Fiorillo Matthew Morreale Mika Reiner Mayer Molly Nichols Natasha Leskovsek Nathan Baum Nicole Peles Nyron Persaud Oyster Point Pharma Ryan Montgomery Ryan Walker Sarah Lightdale Thomas Welk Torys LLP Viatris
